General
Preferred name
BEPRIDIL
Synonyms
BEPRIDIL HYDROCHLORIDE ()
CERM 1978 ()
Bepridil hydrochloride ()
(±)-Bepridil (hydrochloride hydrate) ()
Org 5730 (hydrochloride hydrate) ()
Bepridil (hydrochloride hydrate) ()
Bepridil hydrochloride hydrate ()
1-isobutoxy-2-pyrrolidino-3-(n-benzylanilino)propane hydrochloride ()
Vascor ()
Bepadin ()
Cordium ()
CERM-1978 ()
Unicordium ()
NSC-758390 ()
Bepridil (hydrochloride) ()
P&D ID
PD009942
CAS
74764-40-2
68099-86-5
64706-54-3
49571-05-3
Tags
available
drug
Approved by
FDA
First approval
1990
Drug indication
Chronic/stable angina
Vasodilator
Drug Status
approved
withdrawn
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
The drug bepridil is a racemic mixture of two enantiomers for the 2R as CID 16048570 and 2S as CID 445143. The structure shown here represents the mixture.
(GtoPdb)
DESCRIPTION
Allosteric potentiator of alpha7, alpha4beta2 and alpha4beta4 nAChRs
(Tocris Bioactive Compound Library)
DESCRIPTION
Non-selective calcium channel blocker
(Tocriscreen Plus)
DESCRIPTION
Non-selective Ca2+ channel blocker which stimulates the binding of 1,4-dihydropyridine-based drugs to Ca2+ channels; anti-anginal
(LOPAC library)
DESCRIPTION
Bepridil is an amine Calcium channel antagonist that used to treat angina. But it is no longer sold in the United States. It may be a possible option in the treatment of atrial fibrillation.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Bepridil is an amine Calcium channel antagonist that used to treat angina. But it is no longer sold in the United States. It may be a possible option in the treatment of atrial fibrillation.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
3
Compound Sets
33
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
JUMP-Target 1 Compound Set
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
VGSC-DB
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
74
Molecular Weight
366.27
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
10
Ring Count
3
Aromatic Ring Count
2
cLogP
4.83
TPSA
15.71
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
6.0
QED
0.6
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Ion Channels
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
Calcium Channel
KCNQ4
TNNC1
Primary Target
Non-selective Cav Channels
MOA
Blocker
calcium channel blocker
Indication
angina pectoris
ATC
C08EA02
Therapeutic Class
Antiarrhythmic Agents
VGSC Target
Nav1.5
Source data